featured
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
Approval Marks Significant Advance Towards a More Definitive Assessment of Alzheimer’s Based on Brain Imaging
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: